SAN FRANCISCO, March 9, 2023 /PRNewswire/ — The global ELISA analyzer market size is expected to reach USD 754.38 million by 2030 expanding at a CAGR of 3.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to witness a lucrative growth rate during the forecast period due to its repeated use in detecting infectious diseases, autoimmune diseases, endocrinology, drug monitoring, cardiology, oncology, and allergy testing, among other applications. Moreover, the high adoption rate of immunoassays in research activities is further anticipated to drive growth.
Key Industry Insights & Findings from the report:
- By type, optical grating analyzer is considered to be a relatively more mature segment than optical filter analyzer and held the largest ELISA analyzer market share in 2022, owing to the increasing number of pharmaceutical and biotechnology companies establishing in-house research stations for developing diagnostic tools.
- By Mode, automated analyzers is expected to capture the largest share of the market in 2022. Owing to the increasing investment by governments and international bodies to technologically advance the workflow of clinical diagnostics.
- By application, the immunology segment is anticipated to capture the majority of the market share owing to the increasing incidence of infectious diseases in emerging markets, which is contributing to the growth.
- By end-user, CROs are anticipated to be the fastest-growing segment. This growth can be attributed to the increasing collaborations and strategic partnerships between corporations and CROs that can advance the process of therapeutic formation.
- North America has a dominant regional position with 40.50% of the overall market share. The increasing incidence of chronic & infectious diseases is encouraging companies to enter the regional ELISA analyzers market.
Read 180-page market research report, “ELISA Analyzers Market Size, Share & Trends Analysis Report By Type (Optical Filter Elisa Analyzer, Optical Grating ELISA Analyzers), By Mode, By Application, By End-user, By Region, And Segment Forecasts, 2023 – 2030“, published by Grand View Research.
ELISA Analyzers Market Growth & Trends
ELISA (Enzyme-linked Immunosorbent Assay) is extensively utilized for high-throughput screening of antibodies or drugs. The ELISA analyzer is anticipated to witness healthy growth due to its extensive test portfolio using immunoassay techniques coupled with affordable prices. Furthermore, the changing trends & advancements in medical devices and extensive utilization of immunoassay tests in point-of-care in vitro diagnostics, cancer diagnosis, therapeutic drug level monitoring, & infectious disease testing are factors likely to be responsible for the high growth of this segment.
Continuous technological advancements and the introduction of new products have also contributed to the ELISA analyzers market growth. For instance, in December 2019, Eurofins Abraxis announced to introduce an automatic ELISA analyzer, which comprises a single plate analysis system. The product assists with data analysis and personalized settings to adapt to laboratory testing requirements. The global market is determined by factors such as increasing demand for effective tests to detect hormones, autoimmune diseases, tumor markers, and infectious diseases with the rising number of research institutes worldwide. However, ELISA can only be applied on liquid samples, which proves to be a limitation, hampering its growth over the forecast period.
The growing R&D activities in the areas of immunoassay testing & equipment shall offer abundant opportunities for ELISA analyzers application expansion. These key players are continuously undertaking strategic initiatives to increase their market dominance throughout the forecast period.
In 2022, North America was leading in terms of revenue, followed by the European region. The dominance of North America region is accredited to its well-established market that is motivated by the existence of technologically advanced healthcare infrastructure, the presence of strong market players, and the increasing per capita healthcare expenditure in the region. Moreover, the presence of a huge geriatric population, large cancer & diabetic population, and a well-developed healthcare sector has primarily led to this growth in the U.S.
ELISA Analyzers Market Segmentation
Grand View Research has segmented ELISA analyzers on the basis of type, mode, application, end-users, and region:
ELISA Analyzers Market – Type Scope Outlook (Revenue, USD Million, 2018 – 2030)
- Optical Filter Elisa Analyzers
- Optical Grating ELISA Analyzers
ELISA Analyzers Market – Mode Scope Outlook (Revenue, USD Million, 2018 – 2030)
- Automated ELISA Analyzers
- Semi-Automated ELISA Analyzers
ELISA Analyzers Market – Application Scope Outlook (Revenue, USD Million, 2018 – 2030)
- Immunology
- Vaccine development
- Drug Monitoring
- Others
ELISA Analyzers Market – End-user Scope Outlook (Revenue, USD Million, 2018 – 2030)
- Biotechnology Companies
- Pharmaceutical Companies
- Contract Research Organization
- Diagnostic Laboratories
ELISA Analyzers Market – Regional Outlook (Revenue, USD Million, 2018 – 2030)
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
List of Key players of ELISA Analyzers Market
- Thermo Fisher Scientific
- Abcam
- Bio-Rad Laboratories
- Merck KGaA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- BioTech
- Agilent Technologies
- QIAGEN
- PerkinElmer Inc
Check out more related studies published by Grand View Research:
- Immunofluorescence Assay Market – The global immunofluorescence assay market size is anticipated to reach USD 4.95 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to reach at a CAGR of 5.29% from 2023 to 2030. Immunofluorescence is a traditional technique used for getting insight into cellular processes and structures using microscopy. For instance, specific proteins can be assessed for their location and expression.
- Cell Viability Assays Market – The global cell viability assays market size is expected to reach USD 3.01 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.94% from 2023 to 2030. The rising prevalence of chronic and infectious diseases and the increasing focus on cell-based therapeutics are expanding the growth prospects of the market. In addition, growing funding for cell-based research and increasing use of automated instruments are the key factors driving the market for cell viability assays (CVAs).
- Cellular Health Screening Market – The global cellular health screening market size is expected to reach USD 5.62 billion by 2030, according to a new report by Grand View Research, Inc., expanding at a CAGR of 9.2% from 2022 to 2030. The growing geriatric population and consequent growth in the requirement for cellular health screening are majorly driving the market.
Browse through Grand View Research’s Clinical Diagnostics Industry Research Reports.
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research Helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Grand View Compass | Astra ESG Solutions
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
SOURCE Grand View Research, Inc
